Von Vascular, Inc., a medical device company dedicated to advancing stroke and vascular intervention technologies, today announced the publication of a pivotal pre-clinical research study evaluating the performance of its ALGO Smart Pump.

Von Vascular, Inc., a leading innovator in neurovascular technologies, today announced the first international presentation of data on their ALGO Smart Pump at the BRAIN Conference in London.

Von Vascular, a leader in innovative thrombectomy solutions, was honored to be an esteemed invitee at Medtronic Neurovascular’s Co-Lab during the World Federation of Interventional and Therapeutic Neuroradiology (WFITN) 2024 Congress in New York City.

The Medical Device Technology Symposium, co-chaired by Von Vascular CEO Manning Hanser, I.V. Hall, and Dr. John Hannon of Clemson University, was an overwhelming success. 

Dr. Robert Starke introduced the Complete Clot Ingestion (CCI) metric at SNIS 2024, highlighting the ALGO Smart Pump's potential in stroke thrombectomy.

When it comes to stroke care, time is brain. Every minute lost equates to millions of neurons dying, and the repercussions on a patient's quality of life can be profound. In the pursuit of minimizing these neurological deficits, innovations in stroke thrombectomy devices and techniques are paramount. Among these, the concept of First Pass Efficacy (FPE) and the integration of cyclic aspiration hold significant promise.